Low-dose combo therapy fends off diabetesCanadian trial of rosiglitazone-metformin pill not powered for adverse cardiovascular events Body odour delusion disorder linked with suicidalitySmall study suggests olfactory reference syndrome is under-studied and under-appreciated Alberta nurses recognized with national honours Hybrid therapy tops for H. pylori infection Two-week combined strategy achieves superior eradication rates New protease inhibitor showing promise for hepatitis C Early study suggests experimental drug telaprevir offers option for patients who have not responded to standard treatment First-in-class medications target RA and type 2 diabetes Links found between diet, inflammatory bowel disease Olive oil is protective, high animal protein intake may raise risk Ask the Experts: Treating UTI in patients with poor renal function Is Macrobid or nitrofurantoin effective for UTI in patient's with poor renal function, i.e. CrCl<30mL/min? How much do adverse events cost? Focused research to determine economics of patient safety OPA voices concerns over province's drug system reforms First Previous 3440 3441 3442
